Vanda Pharmaceuticals buy StockNews.com
Start price
14.04.24
/
50%
€3.86
Target price
14.04.25
-
Performance (%)
22.28%
Price
29.08.24
€4.72
Summary
This prediction is currently active. The prediction currently has a performance of 22.28%. This prediction currently runs until 14.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vanda Pharmaceuticals | -2.479% | -2.479% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat